patient reported outcomes | andrew vallance-owen

14
PATIENT REPORTED OUTCOMES International Forum on Quality and Safety in Healthcare Breakfast Session Andrew Vallance-Owen Group Medical Director 7 April 2011

Upload: diagnosisltd

Post on 11-Jun-2015

3.129 views

Category:

Health & Medicine


1 download

DESCRIPTION

A presentation by Andrew Vallance-Owen on Patient Reported Outcomes at the diagnosis Salon on 28th April.

TRANSCRIPT

Page 1: Patient reported outcomes | Andrew Vallance-Owen

PATIENT REPORTED OUTCOMESInternational Forum on Quality and Safety in HealthcareBreakfast SessionAndrew Vallance-OwenGroup Medical Director7 April 2011

Page 2: Patient reported outcomes | Andrew Vallance-Owen

Patient Reported Outcomes – International Forum on Quality and Safety in Healthcare – Amsterdam 2011 7 April 2011 2

BUPA Hospitals rates for clinical indicators(Most indicators <0.5% of discharges)

0.0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1.0

Hospital

% o

f to

tal d

isch

arg

es

% Surgical Deaths

% Transfers

% Re-ops

Page 3: Patient reported outcomes | Andrew Vallance-Owen

Patient Reported Outcomes – International Forum on Quality and Safety in Healthcare – Amsterdam 2011 7 April 2011 3

BUPA Hospitals rates for clinical indicators(What about the other 99.5% of patients?)

0

10

20

30

40

50

60

70

80

90

100

Hospital

% o

f to

tal d

isch

arg

es

% Surgical Deaths

% Transfers

% Re-ops

Page 4: Patient reported outcomes | Andrew Vallance-Owen

Patient Reported Outcomes – International Forum on Quality and Safety in Healthcare – Amsterdam 2011 7 April 2011 4

Generic questionnaire used by NHS

EQ-5D

• 5 questions and a visual analogue scale

• Disadvantage:

◦ Not as sensitive

• Advantage:

◦ Can convert data into QALYs for health economics

Page 5: Patient reported outcomes | Andrew Vallance-Owen

Patient Reported Outcomes – International Forum on Quality and Safety in Healthcare – Amsterdam 2011 7 April 2011 5

EQ-5D

Kind, P. et al. BMJ 1998;316:736-741

Page 6: Patient reported outcomes | Andrew Vallance-Owen

Patient Reported Outcomes – International Forum on Quality and Safety in Healthcare – Amsterdam 2011 7 April 2011 6

Disease-specific vs. generic tools

Trade-off between:

• measuring all health issues affecting patients, and

• using the tool most sensitive to the expected change

Cataracts for example:

• SF-36 shows cataract surgery having negligible benefit, whilst:

• VF-14 shows the same surgery making significant improvement

Page 7: Patient reported outcomes | Andrew Vallance-Owen

Patient Reported Outcomes – International Forum on Quality and Safety in Healthcare – Amsterdam 2011 7 April 2011 7

VF-14 (Visual Function) – extract from 14 questions

Page 8: Patient reported outcomes | Andrew Vallance-Owen

Patient Reported Outcomes – International Forum on Quality and Safety in Healthcare – Amsterdam 2011 7 April 2011 8

0

10

20

30

40

50

60

70

80

90

100

0 3 5 8 11 13 16 19 21 24 27 29 32 35 38 40 43 46 48 51 54 56 59 62 64 67 70 72 75 78 80 83 86 88 91 94 96 99

Percentage of patients (N=824)

VF

-14

sco

re

(10

0 =

no

vis

ua

l p

rob

lem

s)Baseline data can be interesting in their own right:VF-14 pre-op scores, where 100 = no visual problems

Page 9: Patient reported outcomes | Andrew Vallance-Owen

Patient Reported Outcomes – International Forum on Quality and Safety in Healthcare – Amsterdam 2011 7 April 2011 9

PROMS - NHS

Standard NHS Contract for Acute Services, April 2008

requirement to report from April 2009 :

•Other procedures may be added later, e.g. cataract surgery•Future - Long term conditions in primary care

Page 10: Patient reported outcomes | Andrew Vallance-Owen

Patient Reported Outcomes – International Forum on Quality and Safety in Healthcare – Amsterdam 2011 7 April 2011 10

Recruitment varies by procedure% of patients completing baseline questionnaire, NHS data

0.0%

10.0%

20.0%

30.0%

40.0%

50.0%

60.0%

70.0%

80.0%

90.0%

100.0%

Apr-09 May-09 Jun-09 Jul-09 Aug-09 Sep-09 Oct-09 Nov-09 Dec-09 Jan-10 Feb-10 Mar-10 Apr-10 May-10

Groin Hernia Hip Replacement Knee Replacement Varicose Vein

Hips and knees – 70 to 80%

Hernia – 50 to 60%

Varicose vein – 40 to 50%

Page 11: Patient reported outcomes | Andrew Vallance-Owen

Patient Reported Outcomes – International Forum on Quality and Safety in Healthcare – Amsterdam 2011 7 April 2011 11

EQ-5D responsiveness?

Note number “Same” and “Unknown”

Oxford /

Aberdeen

Change (%)

Groin

Hernia

Hip

Replacement

Knee

Replacement Varicose Vein

Increase 95.8% 91.6% 83.7%

Same 0.6% 1.4% 0.1%

Decrease 3.6% 7.0% 16.3%

Unknown 2.5% 3.6% 2.9%

EQ-5D Index

Change (%)

Groin

Hernia

Hip

Replacement

Knee

Replacement Varicose Vein

Increase 49% 87% 77% 53%

Same 33% 6% 11% 33%

Decrease 18% 7% 12% 14%

Unknown 6% 11% 11% 8%

… compared with condition-specific tools:

Page 12: Patient reported outcomes | Andrew Vallance-Owen

Patient Reported Outcomes – International Forum on Quality and Safety in Healthcare – Amsterdam 2011 7 April 2011 12

How NHS data have been presented (as experimental statistics)http://www.hesonline.nhs.uk/Ease/servlet/ContentServer?siteID=1937&categoryID=1295

Groin Hernia - EQ-5D Index - Adjusted Health Gain

0

0.02

0.04

0.06

0.08

0.1

0.12

0.14

0.16

Organisation A National Organisation B

Page 13: Patient reported outcomes | Andrew Vallance-Owen

Patient Reported Outcomes – International Forum on Quality and Safety in Healthcare – Amsterdam 2011 7 April 2011 13

How the NHS data can be shown - funnel plotOxford Hip change scores by hospital, April ’09 to April ’10 dataNHS Experimental Statistics

Hip replacement outcomes (OHS)

10.000

12.000

14.000

16.000

18.000

20.000

22.000

24.000

26.000

28.000

0 50 100 150 200 250 300 350 400 450 500 550 600

Volume (Linked Q1-Q2-HES)

Ca

se-m

ix a

dju

ste

d O

HS

sc

ore

-3σ

mean

+2σ

-2σ

+3σ

Page 14: Patient reported outcomes | Andrew Vallance-Owen

Patient Reported Outcomes – International Forum on Quality and Safety in Healthcare – Amsterdam 2011 7 April 2011 14

The future of PROMS? The ‘howRu’

howRu 35 words

EQ-5D 230 words

SF-12 451 words

SF-36 779 words